Table 3.
Select DPP/DPPOS outcomes evaluated in this analysis
Outcome | Brief definition | Reference no. for detailed description |
---|---|---|
Diabetes | Fasting glucose ≥126 mg/dL or 2-h glucose ≥200 mg/dL, confirmed | 4 |
Cancer | Cancer of any type except for non-melanoma skin cancer | 9 |
Obesity-related cancer | Cancer of the following types: meningioma, multiple myeloma, or cancer of the esophagus, kidneys, uterus, ovaries, thyroid, breast (postmenopausal), liver, gallbladder, upper stomach, pancreas, colon, or rectum | 9 |
Nephropathy | Urine albumin–to–creatinine ratio ≥30 mg/g or eGFR <45 mL/min/1.72 m2 confirmed at next visit or end-stage kidney disease | 10 |
MACE | Major adverse cardiovascular event: nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death | 11 |
Mortality | Death from any cause | 12 |
eGFR, estimated glomerular filtration rate.